About eContinence
eContinence is a Healthcare company based in Ostersund (Sweden) founded in 2021. It operates as an app-based program for treating womens urinary incontinence via exercises, education, and tracking tools. It operates on a B2C model. eContinence offers products and services including Tät App. Its focus areas include Digital Health, Women's Health, Incontinence Treatment and Digital Therapeutics. Its legal entity is eContinence AB. Its competitors include Keleya, Every Mother, Renalis, Liv Labs and Iron Kegel and 1 more; 5 of its 6 listed competitors have raised funding.
Company details
Tät is a mobile app developed by eContinence AB in Sweden, offering a self-treatment program for urinary incontinence based on research from Umeå University. It includes customized exercises, daily reminders, educational content on pelvic floor health, and progress tracking. The app targets women worldwide, helping improve quality of life by reducing leakage symptoms without requiring medical visits. It is CE-marked for safety and efficacy, and available in multiple languages.
- Headquarters Ostersund, Sweden
- SectorsHealthcare
- Website econtinence.app
- Social Instagram
- Legal Name Econtinence Ab
Products & Services of eContinence
eContinence offers a comprehensive portfolio of products and services, including Tät App.
Provides exercises and education for self-treating urinary incontinence effectively.
Apps and channels of eContinence
eContinence publishes 1 mobile app with over 100K+ downloads.
Competitors of eContinence
eContinence has 6 listed competitors in our database, 5 of them funded. They include Keleya, Every Mother, Renalis, Liv Labs and Iron Kegel, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| keleya.de | 2017 | Hamburg, Germany | $3.48M | 18 | App offering exercise and yoga plans for pregnant women | |
| every-mother.com | 2017 | Brooklyn, United States | $1.5M | – | Pregnancy exercises are delivered via an online platform. | |
| renalis.health | 2019 | Chicago, United States | $944,000 | – | Provider of solutions for pelvic health | |
| livlabsfitness.com | 2017 | Wilmette, United States | $125,000 | 3 | Provider of personalized training classes and pelvic floor exercises | |
| ironkegel.pl | 2021 | Wrocaw, Poland | – | – | App for Kegel muscle training to improve men's sexual health and posture. | |
| b-wom.com | 2015 | Barcelona, Spain | $1.08M | – | Develops a mobile app providing guided exercises to strengthen the pelvic area for improved health. |
Detailed competitors of eContinence
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genitourinary Disorders
10 companies that operate in the same segment as eContinence (Genitourinary Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | – | – | |
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction | 2012 | Malvern, Pennsylvania, United States | USD 104.6 M | USD 80.28 M | 209 | |
Therapeutics for infectious and autoimmune diseases are developed. | 2010 | Cambridge, Massachusetts, United States | USD 470.49 M | – | 71 | |
Miniaturized injectable neuromodulation devices are developed for chronic diseases. | 2014 | Santa Clara, California, United States | USD 123.59 M | – | – | |
Developer of a therapeutic solution to treat prostate, kidney, and bladder cancer | 2018 | Maple Grove, Minnesota, United States | USD 157 M | – | 29 | |
A device is developed to treat urinary obstruction from BPH. | 2014 | Palo Alto, California, United States | USD 48 M | – | 25 | |
Minimally invasive devices in urology | 2004 | Mountain View, California, United States | USD 137.96 M | – | 119 | |
Diagnostic devices for lower urinary tract diseases are developed. | 2021 | Aliso Viejo, California, United States | USD 94.99 M | – | 23 | |
Medical device for benign prostatic hyperplasia treatment is developed. | 2021 | Milwaukee, Wisconsin, United States | USD 54.16 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about eContinence
eContinence was founded in 2021.
eContinence is headquartered in Ostersund, Sweden. It is registered at Ostersund, Jamtland, Sweden.
Tät is a mobile app developed by eContinence AB in Sweden, offering a self-treatment program for urinary incontinence based on research from Umeå University. It includes customized exercises, daily reminders, educational content on pelvic floor health, and progress tracking. The app targets women worldwide, helping improve quality of life by reducing leakage symptoms without requiring medical visits. It is CE-marked for safety and efficacy, and available in multiple languages.
eContinence's top competitors include Keleya, Every Mother and Renalis.
eContinence offers Tät App.
eContinence operates through Econtinence Ab.
Yes. eContinence publishes Tät Pelvic floor exercises, with over 100,000 downloads.